All Articles

A modest $350K private placement reveals Vaxil Bio's deep identity crisis as it looks beyond its orphan drug asset for a new path to survival.

In its first major move post-IPO, Atmus acquires Koch Filter, targeting high-growth industrial air filtration for data centers and healthcare.

Aquestive Therapeutics signals commercial readiness for its needle-free allergy film, setting up a high-stakes showdown in the multi-billion dollar market.

As cyber threats escalate in Latin America, one company's strategic acquisitions and localized approach are setting a new standard for regional defense.

A new partnership in Saudi Arabia turns oral health awareness into instant doctor consultations, blurring the lines between marketing and medical access.

Forget national averages. New data shows a fractured luxury market where some cities boom while others use price cuts to reignite sales. Here’s what it means.

Harley-Davidson is clearing debt to invest in the future. Healthcare leaders should take note: this is how you fund a real AI transformation.

Promising 6-month data shows a novel cell therapy could offer durable pain relief for millions suffering from knee osteoarthritis by reprogramming the immune system.

Beyond state-led initiatives, Chinese cities like Linyi are now forging their own trade routes, creating a new model for economic integration in Africa.

Eschewing hype, Chainers built a 600K-player base before its token launch. Now, its $CHU token tests if a 'play-first' model can finally succeed.

As ACL Digital secures AWS Advanced Tier status for a fourth year, we explore why consistent, high-level cloud partnerships are critical for enterprise security.

Céline Gerson's appointment to Enerflex's board signals a strategic push in global markets and energy transition. What does her unique expertise mean?

Kraken's record quarter reveals a masterclass in strategy, leveraging defense trends, smart acquisitions, and heavy investment to conquer the deep.

Australia's top probiotic brand enters Southeast Asia with a high-potency formula. We examine the science behind its claims and its place in the market.

After terminating a mega-merger with Performance Food Group, US Foods charts its own course with a massive share buyback, signaling confidence to investors.

Krispy Kreme's Peanuts collection is more than a treat. It's a masterclass in leveraging nostalgia, strategic partnerships, and brand equity to win the holidays.

A landmark Medicare policy change ends a decades-old rule, granting spinal cord injury patients immediate access to catheters that prevent infection.

Discover how LUNGevity Foundation is cultivating the next generation of researchers to solve lung cancer's most formidable and long-standing challenges.

With a historic $75M investment, Model ML is automating finance's most tedious tasks. Discover how its AI agents are making banks faster and more accurate.

Beyond the hype, the Gulf's patient engagement market is set to explode. We dissect the AI, strategy, and investments driving this healthcare revolution.